Ki67 expression in the primary tumor predicts for clinical benefit and time to progression on first-line endocrine therapy in estrogen receptor-positive metastatic breast cancer

By Delpech Y.  

Breast Cancer Research and Treatment, Vol. 135, Iss. 2, 2012-09 ,pp. : 619-627

Springer Publishing Company

Access to resources Recommend Favorite

The Effect of Onapristone, a Progesterone Antagonist, on the Growth of Human Gastrointestinal Cancer Xenografts

By Jacobs E.   Watson S.A.   Ellis I.O.   Hardcastle J.D.   Robertson J.F.R.  

European Journal of Cancer, Vol. 33, Iss. 7, 1997-06 ,pp. : 1130-1135

Elsevier

Access to resources Recommend Favorite

Vinorelbine, Epirubicin and Fluorouracil as First-Line Therapy in Metastatic Breast Cancer

By Elomaa Inkeri   Joensuu Heikki   Blomqvist Carl  

Acta Oncologica, Vol. 42, Iss. 4, 2003-01 ,pp. : 309-314

Informa Healthcare

Access to resources Recommend Favorite

Vinorelbine as first-line or second-line therapy for advanced breast cancer: A Phase I-II trial by the Danish Breast Cancer Co-operative Group

By Langkjer Sven   Ejlertsen Bent   Mouridsen Henning   Andersen Jørn   Møller Nielsen Mette   Åge Møller Knud   Lindegaard Madsen Ebbe   Haarh Vera  

Acta Oncologica, Vol. 47, Iss. 4, 2008-01 ,pp. : 735-739

Informa Healthcare

Access to resources Recommend Favorite

First-line chemotherapy with docetaxel plus capecitabine followed by capecitabine or hormone maintenance therapy for the treatment of metastatic breast cancer patients

By  

Oncology Letters, Vol. 9, Iss. 2, 2015-01 ,pp. : 987-993

Spandidos Publications

Access to resources Recommend Favorite